A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial
Protease inhibitor-associated hyperglycaemia
[Protease inhibitors].
Fat accumulation and HIV-1 protease inhibitors
Protease Inhibitors
Protease inhibitors.
